Literature DB >> 6660846

Value of serum tests in combined drug therapy of endocarditis.

T A Drake, C J Hackbarth, M A Sande.   

Abstract

Two in vitro tests, the serum killing level and the serum bactericidal rate assays, were evaluated for correlation with therapeutic efficacy in the rabbit model of Staphylococcus aureus endocarditis. Animals were treated with nafcillin alone and in combination with tobramycin or gentamicin. Both were effective therapies, but rapidity of vegetation sterilization by the single and combined regimens was shown by the serum bactericidal rate assay but not the serum killing level assay. As a direct measure of bactericidal activity in serum during therapy, the serum bactericidal rate assay may be a clinically useful supplemental test for providing information that the serum killing level assay cannot.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660846      PMCID: PMC185915          DOI: 10.1128/AAC.24.5.653

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Simple method for elimination of aminoglycosides from serum to permit bioassay of other antimicrobial agents.

Authors:  P Stevens; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

2.  Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

Review 3.  Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis.

Authors:  D L Coleman; R I Horwitz; V T Andriole
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

4.  Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.

Authors:  D T Durack; L L Pelletier; R G Petersdorf
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

5.  Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.

Authors:  M A Sande; M L Johnson
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

6.  Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.

Authors:  C Watanakunakorm; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

7.  Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.

Authors:  Y Van Laethem; H Lagast; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

8.  Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration.

Authors:  C W Stratton; M P Weinstein; L B Reller
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

9.  Dosage schedules of antimicrobial agents: a historical review.

Authors:  C M Kunin
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb
  9 in total
  23 in total

1.  Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.

Authors:  R Garraffo; H B Drugeon; P Dellamonica; E Bernard; P Lapalus
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

2.  Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.

Authors:  P Van der Auwera; J Klastersky; H Lagast; M Husson
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

3.  A pharmacodynamic model for the action of the antibiotic imipenem on Pseudomonas aeruginosa populations in vitro.

Authors:  P H Berg; E O Voit; R L White
Journal:  Bull Math Biol       Date:  1996-09       Impact factor: 1.758

4.  Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis.

Authors:  H F Chambers; S Kennedy
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  Serum bactericidal rate as measure of antibiotic interactions.

Authors:  L L Briceland; M T Pasko; J M Mylotte
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 6.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

7.  Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve.

Authors:  J E Tisdale; M T Pasko; J M Mylotte
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.

Authors:  M Dan; F Poch; C Quassem; R Kitzes
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa.

Authors:  R White; L Friedrich; D Burgess; D Warkentin; J Bosso
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.

Authors:  P Van der Auwera; V Duchateau; C Lambert; M Husson; M Kinzig; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.